Literature DB >> 14561725

Characterization of functional domains of the hemolytic lectin CEL-III from the marine invertebrate Cucumaria echinata.

Yoshiaki Kouzuma1, Yota Suzuki, Masahiro Nakano, Kayo Matsuyama, Sumiki Tojo, Makoto Kimura, Takayuki Yamasaki, Haruhiko Aoyagi, Tomomitsu Hatakeyama.   

Abstract

CEL-III is a Ca(2+)-dependent, galactose/N-acetylgalactosamine (GalNAc)-specific lectin isolated from the marine invertebrate Cucumaria echinata. This lectin exhibits strong hemolytic activity and cytotoxicity through pore formation in target cell membranes. The amino acid sequence of CEL-III revealed the N-terminal two-thirds to have homology to the B-chains of ricin and abrin, which are galactose-specific plant toxic lectins; the C-terminal one-third shows no homology to any known proteins. To examine the carbohydrate-binding ability of the N-terminal region of CEL-III, the protein comprising Pyr1-Phe283 was expressed in Escherichia coli cells. The expressed protein showed both the ability to bind to a GalNAc-immobilized column as well as hemagglutinating activity for rabbit erythrocytes, confirming that the N-terminal region has binding activity for specific carbohydrates. Since the C-terminal region could not be expressed in E. coli cells, a fragment containing this region was produced by limited proteolysis of the native protein by trypsin. The resulting C-terminal 15 kDa fragment of CEL-III exhibited a tendency to self-associate, forming an oligomer. When mixed with erythrocytes, the oligomer of the C-terminal fragment caused hemagglutination, probably due to hydrophobic interaction with cell membranes, while the monomeric fragment did not. Chymotryptic digestion of the preformed CEL-III oligomer induced upon lactose binding also yielded an oligomer of the C-terminal fragment comprising six molecules of the 16 kDa fragment. These results suggest that after binding to cell surface carbohydrate chains, CEL-III oligomerizes through C-terminal domains, leading to the formation of ion-permeable pores by hydrophobic interaction with the cell membrane.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14561725     DOI: 10.1093/jb/mvg157

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  6 in total

1.  Hemolytic lectin CEL-III heptamerizes via a large structural transition from α-helices to a β-barrel during the transmembrane pore formation process.

Authors:  Hideaki Unno; Shuichiro Goda; Tomomitsu Hatakeyama
Journal:  J Biol Chem       Date:  2014-03-20       Impact factor: 5.157

2.  Crystallization and preliminary crystallographic study of oligomers of the haemolytic lectin CEL-III from the sea cucumber Cucumaria echinata.

Authors:  Hideaki Unno; Keigo Hisamatsu; Tomonao Nagao; Yuki Tateya; Naoki Matsumoto; Shuichiro Goda; Tomomitsu Hatakeyama
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-03-28

3.  Differential gene expression at coral settlement and metamorphosis--a subtractive hybridization study.

Authors:  David C Hayward; Suzannah Hetherington; Carolyn A Behm; Lauretta C Grasso; Sylvain Forêt; David J Miller; Eldon E Ball
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

4.  Microarray analysis identifies candidate genes for key roles in coral development.

Authors:  Lauretta C Grasso; John Maindonald; Stephen Rudd; David C Hayward; Robert Saint; David J Miller; Eldon E Ball
Journal:  BMC Genomics       Date:  2008-11-14       Impact factor: 3.969

5.  Expression of putative immune response genes during early ontogeny in the coral Acropora millepora.

Authors:  Eneour Puill-Stephan; François O Seneca; David J Miller; Madeleine J H van Oppen; Bette L Willis
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

6.  Hemolytic C-type lectin CEL-III from sea cucumber expressed in transgenic mosquitoes impairs malaria parasite development.

Authors:  Shigeto Yoshida; Yohei Shimada; Daisuke Kondoh; Yoshiaki Kouzuma; Anil K Ghosh; Marcelo Jacobs-Lorena; Robert E Sinden
Journal:  PLoS Pathog       Date:  2007-12       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.